sun-pharmaceutical - Latest News on sun-pharmaceutical | Read Breaking News on Zee News

Management rejig at Ranbaxy; Arno Gessner replaces Dale Adkisson

Last Updated: Saturday, July 26, 2014, 11:16

Meanwhile the company has made Alexander Gebauer as its new head of global research and development.

Sun Pharma recalls 200 vials of cancer drug: FDA

Last Updated: Thursday, July 03, 2014, 13:22

Sun Pharmaceutical Industries Ltd is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the U.S. Food and Drug Administration said on Thursday.

Ranbaxy gets FDA approval for Novartis' Diovan generic

Last Updated: Friday, June 27, 2014, 09:39

Ranbaxy will be the first rival drugmaker to launch a copy of Diovan in the United States and will be entitled to six months of exclusivity to sell it.

SC asks Andhra HC to decide on Ranbaxy-Sun Pharma merger

Last Updated: Wednesday, May 21, 2014, 14:41

The bench, however, said that shareholders have right to challenge the merger and asked the HC to decide the issue.

Sun Pharma-Ranbaxy merger: SC asks Andhra HC to take decision within 2 days

Last Updated: Wednesday, May 21, 2014, 12:28

The apex court will take up on May 27 the pleas of Sun Pharmaceutical and Ranbaxy challenging interim stay order on merger by HC.

Sun Pharma response to import ban inadequate: USFDA

Last Updated: Tuesday, May 20, 2014, 22:28

The FDA banned imports from Sun Pharma`s Karkhadi plant in Gujarat in March, but the reason for the ban was not clear at that time.

Minority shareholders approval not needed for Sun deal: Ranbaxy

Last Updated: Friday, May 09, 2014, 21:47

Drug major Ranbaxy Laboratories on Friday said it does not require approval from minority shareholders to go ahead with merger deal with Sun Pharmaceutical.

Ranbaxy Q4 net loss at Rs 73.6 cr

Last Updated: Friday, May 09, 2014, 16:24

Drug major Ranbaxy Laboratories on Friday posted consolidated net loss of Rs 73.6 crore for the fourth quarter ended March 31, 2014

Sun Pharma denies unit's role in Ranbaxy share surge

Last Updated: Monday, May 05, 2014, 20:47

Sun Pharmaceutical Industries Ltd, which is to buy rival drugmaker Ranbaxy Laboratories Ltd for USD 3.2 billion, said its unit Silverstreet Developers LLP had no role to play in the run-up in Ranbaxy shares ahead of the deal announcement in April.

Nomura raises Ranbaxy to 'buy' on Sun takeover

Last Updated: Tuesday, April 29, 2014, 11:02

Ranbaxy shares are trading well above the Sun offer that valued the takeover target at 457 rupees apiece.

Ranbaxy's journey as a company to end after merger with Sun

Last Updated: Sunday, April 20, 2014, 12:27

Ranbaxy Laboratories will cease to exist as a company after completion of the USD 4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets.

Crisil reaffirms 'A1+' rating on Ranbaxy's bank facilities

Last Updated: Wednesday, April 09, 2014, 19:36

Rating agency Crisil has reaffirmed its 'A1+' rating on bank facilities of Ranbaxy Laboratories post Sun Pharmaceutical Industries's announcement to acquire 100 percent stake in it.